In terms of gathering medical insights, congresses are unique for several reasons – impromptu interactions with experts, rapidity of engagements, insights from multiple sources including po
Healthware, as the key R&D partner, has been supporting Orion Corporation to design and develop a novel treatment, a Digital Therapeutics software solution "
Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho